Intrinsic Value of S&P & Nasdaq Contact Us

Mesa Laboratories, Inc. MLAB NASDAQ

NASDAQ Global Select • Technology • Hardware, Equipment & Parts • US • USD

SharesGrow Score
37/100
0/7 Pass
SharesGrow Intrinsic Value
$91.05
-8%
Analyst Price Target
$94.00
-5%

Mesa Laboratories, Inc. (MLAB) is a Hardware, Equipment & Parts company in the Technology sector, currently trading at $98.97. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 0 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of MLAB = $91.05 (-8% from the current price, the stock appears fairly valued). Analyst consensus target is MLAB = $94 (-5% upside).

Valuation: MLAB trades at a trailing Price-to-Earnings (P/E) of 133.8 (S&P 500 average ~25).

Financials: revenue is $241M, +9.7%/yr average growth. Net income is $2M (loss), growing at -9129.8%/yr. Net profit margin is -0.8% (negative). Gross margin is 62.6% (+3.4 pp trend).

Balance sheet: total debt is $181M against $160M equity (Debt-to-Equity (D/E) ratio 1.14, moderate). Current ratio is 0.63 (tight liquidity). Debt-to-assets is 41.9%. Total assets: $433M.

Analyst outlook: 3 / 8 analysts rate MLAB as buy (38%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 49/100 (Partial), Growth 40/100 (Partial), Past 50/100 (Partial), Health 17/100 (Fail), Moat 64/100 (Partial), Future 26/100 (Fail), Income 10/100 (Fail).

$94.00
▼ 5.02% Downside
Average Price Target
The 12-month price target for Mesa Laboratories, Inc. is $94.00.

MLAB SharesGrow Score Overview

37/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 49/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 64/100
Gross margin is + market cap
FUTURE 26/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MLAB

~
VALUE Partial
49/100
MLAB trades at a trailing Price-to-Earnings (P/E) of 133.8 (S&P 500 average ~25). Forward PEG -2.02 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.41. Analyst consensus target is $94, implying -5% from the current price $99. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
40/100
MLAB: +9.7%/yr revenue is, -9129.8%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
MLAB: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
17/100
Balance sheet MLAB: Debt-to-Equity (D/E) ratio 1.14 (moderate), Current ratio is 0.63 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
64/100
MLAB: Gross margin is 62.6% (+3.4 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 64/100. ≥ 70 = Pass.
View details →
FUTURE Fail
26/100
Analyst outlook: 3 / 8 analysts rate MLAB as buy (38%). Analyst consensus target is $94 (-5% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
10/100
MLAB: Net profit margin is -0.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range55.45-131.2
Volume87.21K
Avg Volume (30D)109.15K
Market Cap$546.79M
Beta (1Y)0.89
Dividend Yield$0.6400
Share Statistics
IPO Date1984-02-29
Employees736
CEOGary Owens
Financial Highlights & Ratios
Revenue (TTM)$240.98M
Gross Profit$150.87M
EBITDA$42.35M
Net Income$-1.97M
Operating Income$16.34M
Total Cash$27.32M
Total Debt$181.47M
Net Debt$154.15M
Total Assets$433.35M
Price / Sales (P/S)2.27
Analyst Forecast
1Y Price Target$94.00
Target High$94.00
Target Low$94.00
Upside-5.0%
Rating ConsensusHold
Analysts Covering8
Buy 38% Hold 63% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS59064R1095

Price Chart

MLAB
Mesa Laboratories, Inc.  ·  NASDAQ Global Select
Technology • Hardware, Equipment & Parts
55.45 52WK RANGE 131.20
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message